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Abstract
Background: Members of the Kinesin-3 family of kinesin-like proteins mediate transport of axonal
vesicles (KIF1A, KIF1Bβ), distribution of mitochondria (KIF1Bα) and anterograde Golgi to ER
vesicle transport (KIF1C). Until now, little is known about the regulation of kinesin-like proteins.
Several proteins interact with members of this protein family. Here we report on a novel, KIF1
binding protein (KBP) that was identified in yeast two-hybrid screens.
Results: KBP was identified by using the yeast-two-hybrid system with an amino-terminal fragment
of KIF1C as a bait that is strongly homologous to KIF1B. Here we investigated the interaction of
KBP and KIF1B. The full length proteins coimmunoprecipitated after overexpression and in
untransfected 293 cells. Immunofluorescence experiments revealed that KBP was mainly localized
to mitochondria, as has been described for KIF1Bα. Overexpression of a deletion mutant or
reduction of the KBP protein level using an anti-sense construct led to an aggregation of
mitochondria. Such an effect is probably due to the lower activity of KIF1Bα in the absence of KBP,
as was revealed in motility assays.
Conclusion: KBP is a new binding partner for KIF1Bα that is a regulator of its transport function
and thus represents a new type of kinesin interacting protein.
Background
Intracellular transport in cells is mediated by three differ-
ent types of motor proteins that travel along filamentous
tracks. Actin filaments are used by the myosin family of
proteins, while transport along microtubules (MT) is
mediated by either kinesin-like proteins (KLPs) or
dyneins. The functional difference between these two
kinds of molecular motors lies in the polarity of move-
ment. Dyneins transport their cargoes toward the minus
end of MT, while most KLPs transport cargo towards the
minus and plus end of MT, depending on the position of
the motor domain at the amino- or carboxyl-terminus of
the protein (for reviews see [1,2]). The common feature of
all KLPs is a high degree of homology in their motor
domain, a 340 amino acids region that contains MT- and
ATP-binding sites and classifies them into one of 14 fam-
ilies of the kinesin superfamily [3]. Human and mouse
genomes encode 45 KLPs [4] whose functions classically
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are transport of cargo, like protein rafts, lysosomes, chro-
mosomes or various membrane vesicles. However, KLPs
also can zipper, cross-link and influence the stability of
MT for building and maintaining the mitotic and meiotic
spindle apparatus (for reviews see [5-7].
Our previous research identified the protein KIF1C that
localizes to the Golgi apparatus. Using a dominant-nega-
tive mutant we have shown that KIF1C is involved in
transport of vesicles from the Golgi to the ER [8]. Together
with KIF1A and KIF1B, KIF1C belongs to the Kinesin-3
family. The three proteins show a high degree of sequence
homology outside their amino-terminal motor domain
and share a so called U104 domain. The biological func-
tion of this domain, also known as forkhead homology-
associated domain [9] has not yet been described in KLPs
but it may be involved in protein-protein interactions reg-
ulated by phosphorylation. Moreover, KIF1C has been
implicated in the susceptibility of mouse macrophages to
anthrax lethal toxin [10].
The other member of the Kinesin-3 family, KIF1B, is
expressed as two main splicing variants that share 660
amino-terminal amino acids and have different roles in
intracellular transport. The α-isoform associates with
mitochondria [11], while the β-isoforms [12,13]. are
involved in transport of synaptic vesicles and lysosomes
in non-neuronal cells [14]. A missense mutation in the
ATP binding domain of the motor may be causal for the
development of Charcot-Marie-Tooth disease type 2A
[15].
For the Kinesin-3 KLPs several binding proteins were iden-
tified. KIF1A binds to Liprin-α [16], and KIF1Bα interacts
with the PDZ domain of the glucose transporter 1 binding
protein, indicating a possible additional target of this KLP
[17]. In addition, PDZ domains of PSD-90, PSD-97 and S-
SCAM are responsible for interaction with KIF1Bα as well
[18]. We reported previously on the binding of protein
tyrosine phosphatase D1 [8] and 14-3-3 proteins [19] to
KIF1C. Here we describe the identification of a novel
KIF1Bα interacting protein, KBP (KIF1 binding protein).
We show that KBP colocalizes with mitochondria and that
it interacts with KIF1Bα. Moreover, we present evidence
that this new protein plays a role for the regulation of
mitochondrial distribution by regulating the KIF1Bα
activity.
Results
Identification and cloning of KBP
We have previously identified two proteins that bind to
KIF1C, PTPD1 and members of the 14-3-3 protein family
[8,19]. To search for proteins that bind to KIF1C between
the motor domain and the PTPD1 binding region, we
employed the yeast two-hybrid system. Two screens were
made, first with amino acids 435 – 622 as a bait, to iden-
tify possible U104 binding proteins, and second with
amino acids 261 – 800 as a bait. Only the second screen
with the larger bait resulted in possible interacting pro-
teins. Out of 5 × 106 screened transformants, 10 inde-
pendent isolates of the same cDNA were found to interact.
The open reading frame of the identified cDNA encodes a
protein of 621 amino acids (Fig. 1A), with a calculated
molecular mass of 71.8 kDa. A search in the Conserved
Domain Database showed weak homology to tetratr-
icopeptide repeat domains (amino acids 95–241) and
revealed a very acidic region (amino acids 54–64). The
new protein was called KBP (KIF1 binding protein). A pro-
tein BLAST search revealed that the KBP protein sequence
had been identified before and exists in the HUGE Protein
Database as KIAA1279.
Expression of KBP
To estimate the transcript size and prove that the identi-
fied clone encodes the complete open reading frame, as
well as to check the tissue distribution, Northern blot
analysis using the whole cDNA as a probe was performed.
A band of 2.6 kb was detected in all examined tissues, with
the highest expression found in heart and skeletal muscle
(Fig. 1B), which is similar to the expression pattern of
KIF1B, as shown by Nangaku et al. [11] and Chen et al.
[20]. Next, we constructed a glutathione-S-transferase-
KBP (GST-KBP) fusion protein and raised a rabbit poly-
clonal antiserum against it. When probing lysates from
various cell lines with this antibody, a protein of approxi-
mately 72 kDa was detected (Fig. 1C). This is in agreement
with the predicted molecular mass, and the size of the
protein in human cells corresponded with the size of tran-
siently overexpressed protein after transfection, indicating
that we indeed cloned the complete open reading frame.
Localization of KBP in NIH3T3 cells
To elucidate the function of KBP, we performed immun-
ofluorescence experiments utilising affinity-purified anti-
bodies. Immunostaining of NIH3T3 cells revealed that
KBP localized mainly on vesicular structures throughout
the cell, which were reminiscent of mitochondria (Fig.
2A). In the same cells, mitochondria were detected with
MitoTracker (Fig. 2B), and the merged pictures show that
KBP mainly localized to mitochondria (Fig. 2C). These
results suggested that the main cellular binding partner
for KBP is found at the mitochondria.
The KLP KIF1Bα is highly homologous to KIF1C, espe-
cially within the region used for the yeast two-hybrid
screen, and colocalizes with mitochondria [11]. To study
the possible interaction between KBP and KIF1Bα we
cloned the cDNA of human KIF1Bα and raised antibodies
against the carboxyl-terminal part of the protein, a regionBMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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Expression analysis of KBP Figure 1
Expression analysis of KBP. A, amino acid sequence of KBP, probable TPR repeats are boxed. B, expression of KBP mRNA 
in various human tissues was analysed by Northern blot hybridization using the complete cDNA as a probe. The size marker is 
indicated in kilobase. C, expression of KBP in human, mouse and hamster cell lines. Triton cell lysates were separated by SDS-
PAGE, transferred to nitrocellulose and immunoblotted using the KBP antiserum. Size markers are indicated in kDa.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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not present in the KIF1Bβ isoforms. Our antiserum did
not cross-react with the homologous KIF1C and recog-
nized an endogenous protein that was of the same size as
the cloned one (Fig. 3A). We then tested the antiserum in
an immunofluorescence experiment using NIH3T3 cells
and, as expected, detected mitochondria-like structures
(Fig. 3B). Staining along MTs was also visible (Fig. 3B –
top). In a parallel staining, the cells were probed with
MitoTracker, and merging of the pictures indicated an
identical pattern. This experiment confirmed that we had
cloned a human ortholog of the mitochondria binding α-
isoform of the KIF1B protein. In addition, the experiment
suggested that KBP and KIF1Bα colocalize and that colo-
calization likely is mediated through a direct interaction
of the two proteins.
This interaction of KBP and KIF1Bα was confirmed by co-
immunoprecipitation. Transfected 293 cells expressed
either a VSV-epitope tagged form of KBP or KBP-VSV plus
KIF1Bα. Cells were lysed, the proteins immunoprecipi-
tated using anti-KIF1B serum, separated by SDS-PAGE,
transferred to nitrocellulose and blotted with VSV anti-
body. As shown in Fig. 3C, KBP co-immunoprecipitated
with KIF1B when both proteins were overexpressed.
Finally, we tested the interaction of KBP and KIF1B in
untransfected BHK cells (Fig. 3D). After immunoprecipi-
tation of KBP, KIF1B was detected as a co-immunoprecip-
itated protein on a Western blot. In conclusion, KBP
interacts and colocalizes with KIF1Bα.
Deregulation of KBP leads to aggregation of mitochondria
KIF1Bα was identified as a motor protein responsible for
the intracellular transport of mitochondria [11]. Since
KIF1Bα and KBP associated with each other and both pro-
teins localized to mitochondria the question arose
whether KBP could be a link between the motor protein
and this organelle or whether it could play a role in mito-
chondria distribution. To investigate this question we
used two approaches: overexpression of a deletion mutant
of KBP that can not interact any more with KIF1Bα, and
reduction of the KBP expression level using an anti-sense
construct. For the first approach, we employed a deletion
mutant of KBP lacking amino acids 250–281. This region
was chosen because experiments using GST-fusion pro-
teins indicated that the first 305 amino acids are sufficient
for interaction, whereas a mutant lacking the first 214
amino acids was still able to bind KIF1B (data not
shown). KBP∆250–281 was not able to bind to a GST-
KIF1Bα(270–641) fusion protein in a pull-down assay, as
shown in Fig. 4A. When the KBP mutant was overex-
pressed in NIH3T3 cells followed by KBP antibody/
MitoTracker staining (Fig. 4B) a mitochondrial aggrega-
tion was observed in the transfected cells. Overexpression
of intact KBP did not affect mitochondrial localization or
the organization of the microtubule network (data not
shown).
To support these data and to confirm a function of KBP in
mitochondrial distribution in an additional and
Intracellular localization of KBP Figure 2
Intracellular localization of KBP. The localization of KBP was determined by immunofluorescence analysis in untransfected 
NIH3T3 (A) cells, compared to MitoTracker staining (B) and the pictures subsequently merged (C). Bars, 10 µm.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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Expression of human KIF1Bα and interaction with KBP Figure 3
Expression of human KIF1Bα and interaction with KBP. A, lysates of 293 cells overexpressing KIF1Bα, KIF1Bα-myc 
and KIF1C or of untransfected 293 cells (10 fold amount of protein) were separated by SDS-PAGE, transferred to nitrocellu-
lose and blotted with antiserum raised against the carboxyl-terminal part of KIF1Bα. B, affinity purified antibodies against 
KIF1Bα (top) and MitoTracker (middle) were used to stain NIH3T3 cells. The merged picture is shown at the bottom. Bar, 20 
µm. C, KIF1Bα was immunoprecipitated from lysates of 293 cells overexpressing KBP-VSV either alone or together with 
KIF1Bα. Analysis was done as described and blotting performed with VSV monoclonal antibody. To confirm expression of the 
proteins, the filter was reprobed with KIF1Bα antibody, while KBP-VSV expression was detected in a separate aliquot of the 
cell lysates. D, untransfected BHK cells were lysed, proteins immunoprecipitated with the indicated antibodies against GST 
(control), KBP and KIF1Bα and analysed as before by blotting with anti-KIF1B antibody. Molecular mass markers are shown in 
kDa.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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independent approach, we cloned the KBP cDNA in a
reversed orientation into the cytomegalovirus promoter
based expression vector. Transfection of this construct
into 293 cells reduced the expression of endogenous KBP
to an overall 30%, when compared to untransfected cells
and as detected by blotting analysis (Fig. 5A). Based on
Expression of KBP∆250–281 leads to aggregation of mitochondria Figure 4
Expression of KBP∆250–281 leads to aggregation of mitochondria. A, 1 µg of GST-KIF1Bα fusion protein was incu-
bated with equal amounts of lysates from either KBP or KBP∆250–281 expressing 293 cells. As a control, GST-Grb2 fusion 
protein was used. The proteins were separated by SDS-PAGE, transferred to nitrocellulose and immunoblotted with GST-KBP 
antiserum (left panel). To confirm expression of KBP and the KBP deletion mutant, an equal amount of each lysate was loaded 
on the gel and analysed with KBP antiserum (right panel). Molecular mass markers are shown in kDa, and an arrow indicates 
the position of KBP. B, NIH3T3 cells transiently overexpressing the KBP∆250–281 mutant protein were costained with KBP 
antibody (upper picture) and MitoTracker (lower picture). Trf, transfection; bar, 10 µm.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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KBP is essential for a regular distribution of mitochondria in NIH3T3 cells Figure 5
KBP is essential for a regular distribution of mitochondria in NIH3T3 cells. A, a scheme of the anti-KBP plasmid is 
depicted. The reduction of endogenous KBP in 293 cells after transient transfection with the anti-KBP plasmid is shown. (B, C) 
NIH3T3 cells were transiently transfected with anti-sense KBP and 14-3-3γ-HA constructs in a 10:1 ratio, respectively, and 
costained with HA monoclonal antibody (B), and MitoTracker (C). As a control, NIH3T3 cells were transiently transfected 
with 14-3-3γ-HA only (D, E). Similar as in B-E, cotransfection with GFP was performed (F-I). Alternatively, anti-sense KBP 
transfected cells were stained with antibodies against β-tubulin (J) and with MitoTracker (K). Arrows in J, K indicate trans-
fected cells. The merged picture of J and K is shown in (L). Trf, transfection; bars, 20 µm.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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FACS-analysis of transfected cells, we assume a transfec-
tion efficiency of some 80% with our protocol. This
would predict a down-regulation of the KBP protein level
to less than 20% in an individual transfected cell. Trans-
fected cells were marked for immunofluorescence inspec-
tion by including a plasmid encoding HA-epitope tagged
14-3-3γ in the transfections at a 1:10 ratio. 14-3-3 proteins
are very abundant in cells and, as concluded from experi-
ments with 293 cells [19], their expression level is only
increased two- to threefold after transfection using opti-
mal amounts of DNA. Therefore, we did not expect an
impact of exogenous 14-3-3γ-HA on the mitochondrial
distribution process. After transfection, cells were double-
stained with monoclonal anti-HA antibodies to identify
the transfected cells and with MitoTracker to investigate
effects of a reduced KBP expression on mitochondria. In
Fig. 5B,C, two cells are in the frame of the picture, and the
upper cell has been transfected and therefore stained with
the HA-antibody. In C, staining of the mitochondria
revealed the regular distribution in the untransfected cell,
but an aggregated status in the transfected cell that would
contain a reduced amount of KBP. To confirm that this
effect was not the result of 14-3-3γ-HA overexpression,
NIH3T3 fibroblasts were transfected with the 14-3-3γ-HA
expression plasmid alone and anti-HA antibody/
MitoTracker staining was performed. Fig. 5D,E show that
overexpression of 14-3-3γ-HA did not cause the mito-
chondria to aggregate. In addition, when similar experi-
ments were conducted using overexpression of GFP
similar results were obtained (Fig. 5F–I). To exclude the
possibility that mitochondrial aggregation is a result of
MT depolymerization or changes in the cell shape, the
NIH3T3 cells were transfected with the anti-sense KBP
construct and costained with β-tubulin antibody and
MitoTracker. In this experiment, mitochondrial clumping
was used as a marker of transfection. As seen in pictures J
to L of Fig. 5 the clustering of mitochondria was not
accompanied by either MT depolymerization or cell
shrinking. To conclude, both experiments clearly show
the importance of KBP for the distribution of mitochon-
dria in cells.
Mitochondria aggregation and the role of KBP
The above results did not answer the question whether
KBP is a mitochondrial receptor for KIF1Bα and is medi-
ating the interaction KIF1Bα/mitochondria. We therefore
analysed the localization of KIF1Bα in cells with a reduced
KBP expression. As described before, cells were transfected
with the anti-sense KBP construct and transfected cells
identified by staining with MitoTracker. In addition, cells
were stained with KIF1Bα antibody. As seen in Fig. 6A
(top), a perinuclear localization of mitochondria indi-
cates transfection with the anti-sense KBP construct. The
bottom picture shows perinuclear localization of KIF1Bα
and colocalization with aggregated mitochondria. This
suggests that KIF1Bα is still associated with the mitochon-
dria after down-regulation of KBP and that KBP does not
function as an adapter.
In addition to KIF1B, conventional kinesin (KIF5B) also
was described to mediate transport of mitochondria [21].
To confirm a specific role of KBP for KIF1Bα and not
KIF5B, we tested the interaction between these proteins.
Therefore, we constructed a plasmid encoding a GST
fusion protein encoding amino acids 265–639 of KIF5B,
corresponding to the previously used GST-KIF1Bα. Pro-
teins were purified from bacteria and incubated with glu-
tathione-sepharose and lysates from 293 cells transiently
overexpressing KBP. As indicated in Fig. 6B, only GST-
KIF1Bα associated with KBP. Neither GST-KIF5B nor GST-
Grb2 (as a control) were able to bind KBP. The GST-fusion
proteins are visible since the anti-KBP antiserum was gen-
erated using a GST-KBP fusion protein and indicate that
similar amounts were used for the pull-down.
The above finding suggests that KBP does not bind the
KIF1Bα's carboxyl-terminus, which was shown to mediate
cargo interactions [16,22]. To identify the KBP-binding
site on KIF1Bα we generated a mutant with an amino-ter-
minal truncation of 349 amino acids (KIF1Bα350-1135-
VSV) which was not able to bind KBP (Fig. 6C). Together
with the data presented in Figure 6B this confines the
binding of KBP to KIF1Bα between amino acids 270 and
350 at the carboxyl-terminus of the motor domain. Thus,
KBP plays an important role in mitochondria distribution
in cells but it is neither a mitochondrial receptor nor a
general adapter protein for mitochondria transporting
KLPs.
KBP improves KIF1B motility
KBP does not mediate the association of KIF1Bα with
mitochondria since it is still found there when KBP is
depleted. We therefore hypothesized that KBP could
either increase the time of association of KIF1Bα with MT,
or it could influence the motility of the KIF1Bα motor
domain. To investigate this hypothesis we used latex
beads in in vitro motility assays. Extracts were prepared
from untransfected HeLa cells or from HeLa cells overex-
pressing KIF1Bα together with KBP or the KBP deletion
mutant (Fig. 7A). Extracts from untransfected cells served
as control for unspecific moving. The unspecific move-
ments could be attributed to the large amount of kinesin
heavy chain present in the extract (Fig. 7A), which bound
beads. The KIF5B can be inhibited by SUK4 antibody [23],
and indeed treatment of extracts with the antibody
strongly reduced motility in HeLa extracts. Inhibition of
unspecific movements could be further improved by coat-
ing the beads with KIF1B antibody. Both treatments
together reduced the amount of moving beads by about
90% (Fig. 7B, bars 1,2). Upon overexpression of KIF1BαBMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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KIF1Bα colocalizes with aggregated mitochondria Figure 6
KIF1Bα colocalizes with aggregated mitochondria. A, NIH3T3 cells were transfected with anti-sense KBP and cos-
tained with MitoTracker (upper picture) and KIF1Bα polylonal antibody (lower picture). Bar, 10 µm. B, 1 µg of KIF1Bα and 
KIF5B GST-fusion proteins were bound to glutathione Sepharose and incubated with equal aliquots of the same lysate from 
KBP expressing 293 cells. As a control, GST-Grb2 fusion protein was used. The proteins were separated, transferred to nitro-
cellulose and immunoblotted with GST-KBP antiserum. Molecular mass markers are shown in kDa, and an arrow indicates the 
position of KBP. Trf, transfection. C, KBP was transiently overexpressed either alone or together with KIF1Bα-MYC or 
KIF1Bα350-1135-VSV. Proteins were immunoprecipitated with either VSV or MYC antibody and KBP was detected with the 
specific antibody. The filter was reprobed with KIF1B antibody, and KBP expression was confirmed as before.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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KBP increases the motility of KIF1Bα Figure 7
KBP increases the motility of KIF1Bα. A, extracts were prepared from HeLa cells that were either untransfected or 
transfected with KIF1Bα and KBP or KBP∆251–281. The cells were cracked and cytosolic extracts separated by SDS-PAGE 
(20 µg of total protein) transferred onto nitrocellulose and blotted with KIF1B (top panel), KBP (midddle panel) and ubiquitous 
kinesin antibodies (bottom panel). B, uncoated or KIF1B antibody coated beads moving on MT sedimented on coverslips in 
flow cells were counted. Movements of beads were observed using VE-DIC in HeLa extracts as described in the Methods sec-
tion. Each bar represents the number of beads counted during 5 minutes of observation on 10 planes in 3 independent experi-
ments, where each plane was observed for 30 sec. C, distances traveled by beads in a particular extract were determined using 
RETRAC software. The total number of analysed beads (n) is indicated below each histogram.BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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together with KBP the number of moving beads was
significantly higher than in extracts from untransfected
cells. This number was not affected by additional co-over-
expression of the KBP deletion mutant (Fig. 7B, bars 3 and
4). Therefore, we assume that more than 60% of the
observed movements was caused by the overexpressed
KIF1Bα. When analysing the velocities of moving beads,
we noticed that the deletion mutant slightly decreased the
velocity of the beads as compared with the wild type
(Table 1). Most striking was the strong reduction of the
distance traveled by beads in extracts coexpressing
KBP∆250–281, most of which was shorter than 1 µm,
while in extracts coexpressing wild type KBP the beads
traveled longer than 2 µm (Fig. 7C; for average values see
Table 1). Taken together, our results indicate that KBP
increases the motility of KIF1Bα.
Discussion
In the present study we report on the identification of the
new KIF1 binding protein KBP. The association of KBP
with KIF1Bα was verified in vitro, in 293 cells transiently
overexpressing both proteins and in untransfected BHK
cells. Anti-sense experiments revealed that KBP is required
for a proper distribution of mitochondria in the cell.
Finally, we showed that KBP increases KIF1Bα motility in
vitro.
The bait used in the yeast two-hybrid screen that led to the
identification of KBP contained the sequence from the
motor domain to the PTPD1 binding region (amino acids
261–800). Additional data from binding experiments of
KBP to KIF1C and KIF1Bα deletion mutants allowed us to
narrow down the binding sequence of KIF1B/C for KBP to
the carboxyl-terminal region of the motor domain. A high
amino acid sequence homology of 90% between KIF1C
and KIF1Bα in this region supports the conclusion that
KBP can bind to both proteins, and a manuscript describ-
ing the role of KBP for KIF1C is in preparation. It is impor-
tant to note that the binding region of KBP is located close
to the K-loop, a region in KIF1 KLPs that increases the
affinity of the motor domain for MT [24]. For KIF1B, sev-
eral splice variants involving or located next to the K-loop
are known [13], and it will be interesting to check whether
the presence of these variants has an effect on interaction
with KBP [12]. An interaction with the KIF1Bβ variant
would open a role for KBP as a player in neurodegenera-
tive diseases. Recently, the role of the K-loop in a 679
amino acid construct of the rat orthologue of KIF1C was
analysed [25]. In in vitro experiments this protein was not
chemically processive, the K-loop increased the affinity for
MT and stabilized a weak binding mode with ADP in the
active site. The hypothesis was formed that rat KIF1C
could work in teams of motor proteins, which could
generate processive movement of attached organelles.
This would be a similar mechanism as proposed for KIF1A
[22]. In our motility assays we observed that KBP
increased the motility of beads in extracts from KIF1Bα
overexpressing cells. When the motor protein was overex-
pressed with KBP, it traveled average distances of 2–3 µm
and maximally 6 µm, while with KBP∆251–281 we
observed KIF1Bα moving an average of 1 µm. These
experiments do not contradict the data of Rogers et al. and
Klopfenstein et al. since it is possible that KBP facilitates
grouping of motor proteins and thus increases the motil-
ity. However, it also indicates an alternative mechanism
where associated proteins like KBP could increase the
motility of single molecules of KIF1B.
Numerous proteins have been identified that interact with
KLPs [26,27]. These proteins may determine the localiza-
tion of the KLP complex or which cargo is transported.
Very little, however, is known about associating proteins
that regulate either the cargo binding of the KLP or its
activity. Such a KLP associating protein that is required for
the KLP function has been described in yeast. The MT
minus-end directed motor protein Kar3p is important for
meiosis I in S. cerevisiae, and a knock out leads to an arrest
in prophase I [28]. The associating protein Cik1p targets
Kar3p to MT, implicating this as a reason why loss of
Cik1p also impairs meiosis, although the effect is less
severe [29]. Several studies describe a regulatory role of
the carboxyl-terminus in conventional kinesin processiv-
ity. Kinesin light chains were reported to inhibit the bind-
ing of the heavy chain to MT [30]. Further, the kinesin tail
domain by itself has an ATPase inhibiting role that is
relieved by cargo binding [31-33]. One function of the
light chains and the carboxyl-terminus of the heavy chain
may thus be to ensure that kinesin is active only in the
Table 1: Summary of data from motility assays. Average values for velocities and distances traveled by beads are shown.
Lysate Max velocity Distance traveled along MT
[µm/s] St. error [µm] St. error
KIF1B /KBP (n = 61) 0.82 0.022 2.32 0.15
KIF1B/KBP∆250–281 (n = 67) 0.69 0.02 1.07 0.098
P-value 2.92E-05 1.25E-09BMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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presence of its cargo. However, most of these studies have
been done in vitro and cannot account for effects of regu-
lating proteins.
The drastic consequences of the loss of KBP expression for
mitochondria localization could also indicate that KBP is
targeting KIF1Bα to the mitochondria. However, KIF1Bα
is attached to mitochondria also after depletion of KBP
(Fig. 6A). In addition, KLPs normally bind their cargo
with carboxyl-terminal sequences, whereas KBP interacts
with KIF1Bα amino-terminal sequences. Therefore, we do
not think that KBP is important for the cargo – kinesin
connection. Alternatively and mentioned before, KBP
may regulate the KIF1Bα activity, i.e., in the absence of
KBP, KIF1B is not or less able to move mitochondria.
Only two widely expressed KLPs have been reported to
transport mitochondria, KIF1Bα and KIF5B, while KIF5A
and KIF5C are expressed predominantly in neuronal tis-
sues [34]. KIF5B did not interact with KBP, and it should
not be affected by KBP depletion. Thus, even if there is
some expression of KIF5B, a major role of KIF1Bα for
mitochondria transport in NIH3T3 cells is likely.
Recently, the Drosophila protein MILTON was described
that associates with the KIF5 ortholog kinesin heavy chain
and may play a role similar to KBP since its mutation
impairs MT-plus end directed mitochondrial transport in
axons and synapses [35]. In addition to KLPs, dynein
motor proteins probably can transport mitochondria in
cells [36], and this transport would occur in a MT minus-
end direction. When force moving mitochondria to the
MT plus-ends is reduced, a perinuclear localization of the
mitochondria would result. On the other hand, a com-
plete depolymerization of MTs by nocodazole treatment
led to a diffusion of mitochondria throughout the cyto-
plasm [21], demonstrating the specificity of the conse-
quences of KBP depletion.
Conclusion
We have shown earlier that protein tyrosine phosphatase
D1 and members of the 14-3-3 protein family interact
with KIF1C, implying its regulation by phosphorylation.
In this manuscript, we have identified the new protein
KBP as a KLP interacting protein that is required for KLP
activity. This suggests that vesicle transport in cells may be
subject to regulation at the level of KLP – microtubule
interaction and implicates KBP as a physiological
mediator.
Methods
Yeast two-hybrid screen
Two fragments of the KIF1C cDNA encoding amino acids
435–622 (corresponding to the U104 domain) or amino
acids 261–800 were cloned into the LexA fusion protein
vector pBTM116 and transformed into the Saccharomyces
cerevisiae strain L40 (MATa trp1 leu2 his3 LYS2::lexA-HIS3
URA3::lexA-lacZ [37]), generating the L40 LexA-
KIF1CU104 and L40 LexA-KIF1C298–840 strains, respectively.
A brain cDNA library fused to the GAL4 activation
domain in the pACT2 vector (Clontech) was transformed
into the L40 LexA-KIF1CU104 and L40 LexA-KIF1C298–840
strains and 5 × 106 transformants were screened for inter-
action as described [38]. Yeast plasmid DNA was isolated
from His+ β-Gal+ colonies, rescued into Escherichia coli
HB101, retransformed into L40 LexA-KIF1C298–840, and
yeasts assayed for β-galactosidase activity and growth on
medium with complete supplement lacking amino acids
Trp, Leu, Ura, Lys, and His (Bio101). The specificity of the
interaction between KIF1C298–840 fragment and potential
candidates was proven by transforming the candidate
plasmid also into a L40 LexA and a L40 LexA-laminin
strain.
DNA sequence analysis
Clones interacting specifically with KIF1C in the two-
hybrid screen were subjected to sequencing by the dideox-
ynucleotide chain termination method. Non-redundant
databases (GenBank, EMBL, DDBJ and PDB) were
searched for homologous sequences using the BLAST pro-
gram [39,40].
Northern blot analysis
A multiple tissue Northern blot was obtained from Clon-
tech. Hybridization was performed at 67°C with 5 × 106
cpm/ml of 32P-random primed DNA probe as described
by the manufacturer.
cDNA cloning and protein purification
For transient expression in 293 and NIH3T3 cells, all
cDNAs were cloned by standard procedures into the
cytomegalovirus immediate early promoter-based expres-
sion plasmid pRK5 [41]. To clone a KIF1Bα encoding
cDNA, the 3'-part of the open reading frame was received
from clones FH12320 (1941–3721 bp of this clone) and
HJ02790 (1–685 bp of this clone) known in HUGE Pro-
tein Database as genes KIAA1448 [42] and KIAA0591
[43], respectively. The 5'-part was amplified in a PCR reac-
tion using a human brain cDNA library as a template. A
cDNA fragment encoding the amino acids 265–639 of the
human version of KIF5B was amplified with specific prim-
ers in a similar way. The corresponding region of KIF1Bα
(amino acids 270–641) was cut out from the KIF1Bα
cDNA using restriction enzymes, and both fragments were
cloned into a pGEX vector. The corresponding fusion pro-
teins were produced in Escherichia coli BL21 (Novagen) or
298 F' strains and purified as described [44].
Antisera
The KIF1B and KBP rabbit polyclonal antisera were raised
against glutathione-S-transferase (GST) fusion proteins ofBMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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KIF1B (amino acids 743–1153) and KBP (full length),
respectively. Monoclonal antibodies used were derived
from the following hybridoma: kinesin heavy chain – H2;
phosphotyrosine – 4G10; β-tubulin – KMX1; vesicular
stomatitis virus (VSV) epitope tag – p5d4; KIF5 – SUK4;
hemagglutinin (HA) epitope tag – 12CA5.
Cell lines and cell culture
293 cells were grown in F12/Dulbecco's modified Eagle's
medium supplemented with 10% fetal calf serum and 2
mM glutamine. BHK, HeLa, NIH3T3 and C2C12 cells were
maintained in Dulbecco's modified Eagle's medium sup-
plemented with 10% fetal calf serum and 2 mM
glutamine.
Transient expression, cell lysis, and immunoprecipitation
Transfection of 293 cells and NIH3T3 cells was performed
using the method of Chen and Okayama [45]. The cells
were lysed in 1 ml of lysis buffer/10-cm plate (1% Triton
X-100, 50 mM HEPES, pH 7.5, 10% glycerol, 150 mM
NaCl, 1.5 mM EGTA, 10 mM sodium pyrophosphate, 100
mM NaF, 1 mM sodium orthovanadate, 10 µg/ml apro-
tinin, 1 mM phenylmethylsulfonylfluoride) and the
lysates were precleared by centrifugation at 13,000 g for
15 minutes at 4°C. The lysates were adjusted for equal
protein concentration, the appropriate antibody (3 µl of
serum or 2 µg of purified antibody) and either Protein A-
or Protein G-Sepharose were added, and the lysates were
incubated for at least 3 hours at 4°C on a turning wheel.
The immunoprecipitates were washed with HNTG buffer
(20 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-
100, 10% glycerol, 10 mM NaF, 1 mM sodium orthovana-
date), separated on an 8 or 10% SDS-polyacrylamide gel,
transferred to a nitrocellulose membrane, and incubated
with the appropriate primary antibody. After three
washes, the membranes were incubated with secondary
horseradish peroxidase-conjugated goat anti-mouse or
goat anti-rabbit antibodies (Sigma). After three washes
they were visualized using the ECL system. Before reprob-
ing, blots were incubated for 30 minutes in 62.5 mM Tris-
HCl, pH 6.8, 2% SDS, and 0.1% β-mercaptoethanol at
55°C.
In vitro binding assays
For in vitro binding assays, 293 cells transiently overex-
pressing KBP were lysed and incubated for 4 hours at 4°C
with GST or GST-KIF1Bα/KIF5B fusion proteins immobi-
lized on glutathione-Sepharose. After washing with
HNTG buffer, the proteins were separated by SDS-PAGE
and analysed by Western blotting.
Immunofluorescence
NIH3T3 cells were grown on uncoated glass coverslips,
fixed for 20 minutes in ice-cold methanol at -20°C,
washed with phosphate-buffered saline and incubated for
10 minutes with 0.1% NaBH4 and 0.1 M glycine in phos-
phate-buffered saline to block autofluorescence. Nonspe-
cific antibody binding was blocked for 45 minutes with
PBS with 0.045% fish gelatin containing 5% normal goat
serum and 1% bovine serum albumine. Incubation with
primary antibody was done for 1.5 hours at 37°C after
dilution in PBS/gelatin containing 5% normal goat
serum. The affinity purified KBP and KIF1Bα antibodies
were used at concentrations of 10 ng/µl and 20 ng/µl,
respectively. The β-tubulin antibodies were diluted as rec-
ommended by the manufacturer, and the monoclonal
VSVantibodies at a concentrations of 20 ng/µl. After five
washes with PBS/gelatin, primary antibody binding was
detected with isotype-specific secondary antibody conju-
gated with either DTAF (goat anti-rabbit, Dianova) or
Alexa (Alexa Fluor 546 goat anti-mouse and goat anti-rab-
bit and Alexa Fluor 488 goat anti-mouse, Molecular
Probes). The coverslips were mounted in PermaFluor
(Immunotech). To allow unbound protein to diffuse out,
extraction of cells with 0.5% Triton X-100 was performed
prior to fixation for 5–10 seconds [46,47]. MitoTracker
(Molecular Probes) staining was done according to man-
ufacturer's recommendations.
Pictures were taken with a Leica TCS NT/SP Laser Scan-
ning Confocal Microscope supplied with HCX PL APO
immersion oil objective of magnification 63× and aper-
ture 1.32–0.62. The pictures were prepared using TCS soft-
ware supplied by the manufacturer.
Cell extracts and motility assays
Cell extracts were prepared in BRB80 buffer (80 mM
Pipes, pH 6.8, 2 mM MgCl2, 1 mM EGTA) supplemented
with protease inhibitors, through multiple passing
through cell cracker (HGM, Heidelberg, Germany). The
nuclei were spun down and the supernatant was spun
again at 120,000 g to separate cytosol from membrane
fraction The concentration of the cytosolic fraction was
adjusted to 1 mg/ml and supplemented with 1 mM DTT,
20 µM taxol, 2 mg/ml BSA, 5 mg/ml casein and 1/20 vol-
ume energy mix (150 mM creatine phosphate, 20 mM
ATP, 20 mM MgCl2, 2 mM EGTA, pH 7.7).
For motility assays with latex beads, 1 µl of beads (2.5%
solid-latex, carboxylate 0.1 micron microspheres; Poly-
sciences, Inc., Warrington) was left untreated or incubated
for at least 30 minutes with 4 µl of KIF1B antibody solu-
tion (3 mg/ml). Then the antibody/beads suspension was
diluted 1:6 in BRB80, 1 mM DTT, 20 µM taxol, 2 mg/ml
BSA, 5 mg/ml casein and 1/20 volume energy mix. One µl
of beads was mixed with 9 µl of cell extract and floated
into a flow cell with coverslips coated with microtubules.
The beads were left for 5 – 7 minutes in a humid chamber
to sediment onto the microtubules. To inhibit unspecific
KIF5B driven movements, SUK4 antibody was incubatedBMC Cell Biology 2005, 6:35 http://www.biomedcentral.com/1471-2121/6/35
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with extracts for 10 minutes at a final concentration of
0.25 mg/ml, and then the extracts were used in the assay.
Flow cells were prepared as described earlier [48], and
microtubules were isolated from pig brain as described
[49].
Motility was observed using video-enhanced differential
interference contrast microscopy (VE-DIC) in real time
(Olympus optics BX60 microscope, equipped with DIC
optics; Japan, Tokyo). To determine the rates and dis-
tances, RETRAC software (Dr. N. Carter, Marie Curie
Research Institute, Oxted, Surrey, UK) was used.
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